L. Johnston

发表

Head-to-head Comparison of Qualitative Radiologist Assessment With Automated Quantitative Computed Tomography Analysis for Bronchiolitis Obliterans Syndrome After Hematopoietic Cell Transplantation

A. Leung, H. Guo, J. Hsu, 2021, Journal of thoracic imaging.

The safety and tolerability of pirfenidone for bronchiolitis obliterans syndrome after hematopoietic cell transplant (STOP-BOS) trial

J. Hsu, H. Sharifi, Paulami Chatterjee, 2022, Bone Marrow Transplantation.

FAM treatment for new onset bronchiolitis obliterans syndrome after hematopoietic cell transplantation

J. Pidala, Stephanie J. Lee, M. Flowers, 2016 .

Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation.

B. Storer, J. Pidala, Stephanie J. Lee, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The safety and tolerability of pirfenidone for bronchiolitis obliterans syndrome after hematopoietic cell transplant (STOP-BOS) trial

J. Hsu, H. Sharifi, Paulami Chatterjee, 2022, Bone Marrow Transplantation.

Effect of Antihuman T Lymphocyte Globulin on Immune Recovery after Myeloablative Allogeneic Stem Cell Transplantation with Matched Unrelated Donors: Analysis of Immune Reconstitution in a Double-Blind Randomized Controlled Trial.

J. Ritz, P. Westervelt, J. Dipersio, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The Effect of Normothermic Machine Perfusion on the Immune Profile of Donor Liver

J. Donington, J. Millis, R. Barth, 2022, Frontiers in Immunology.

Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy.

M. Bar, J. Wagner, J. Sierra, 2021, Transplantation and cellular therapy.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report.

Anita Lawitschka, Stephanie J. Lee, K. Syrjala, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host disease.

B. Storer, P. Westervelt, F. Appelbaum, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic cell transplantation from related and unrelated donors after minimal conditioning as a curative treatment modality for severe paroxysmal nocturnal hemoglobinuria.

R. Storb, D. Niederwieser, E. Holler, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation.

H. Deeg, R. Storb, B. Storer, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Lung Function Trajectory in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplant.

B. Storer, J. Pidala, Stephanie J. Lee, 2016, Annals of the American Thoracic Society.

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation.

J. Ritz, P. Westervelt, J. Dipersio, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of admission body weight and chemotherapy dose adjustment on the outcome of autologous bone marrow transplantation.

R. Negrin, J. Shizuru, K. Stockerl-Goldstein, 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Retrospective caseecontrol study of the effects of long-term dosing with meloxicam on renal function in aged cats with degenerative joint disease

R. Malik, W. Stansen, L. Johnston, 2022 .

Geriatrics assessment in older adults referred for hematopoietic cell transplantation

V. Periyakoil, L. Johnston, P. Sossenheimer, 2022, Journal of the American Geriatrics Society.

Sleep disruption in hematopoietic cell transplantation recipients: prevalence, severity, and clinical management.

S. Kesler, H. Jim, J. Pidala, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Machine learning algorithms to differentiate among pulmonary complications after hematopoietic cell transplant.

J. Hsu, H. Sharifi, M. Nicolls, 2020, Chest.

Encouraging Results of a Phase II Trial of Inhaled Fluticasone Propionate, Azithromycin, and Montelukast (FAM) May Maintain Lung Function in Bronchiolitis Obliterans Syndrome (BOS) after Hematopoietic Cell Transplantation

B. Storer, J. Pidala, Stephanie J. Lee, 2015 .

Clinical Research: Supportive CareFluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation

B. Storer, J. Pidala, Stephanie J. Lee, 2016 .